| dc.contributor.author | Xie, Qing | |
| dc.contributor.author | Zhang, Qin | |
| dc.contributor.author | Sonneveld, Milan J. | |
| dc.contributor.author | Zhang, Ning-Ping | |
| dc.contributor.author | Tabak, Fehmi | |
| dc.contributor.author | Janssen, Harry L. | |
| dc.contributor.author | Hansen, Bettina E. | |
| dc.contributor.author | Verhey, Elke | |
| dc.contributor.author | van Vuuren, Anneke J. | |
| dc.contributor.author | Diculescu, Mircea. | |
| dc.contributor.author | de Niet, Annikki | |
| dc.contributor.author | İDİLMAN, RAMAZAN | |
| dc.contributor.author | Wang, Jiyao | |
| dc.contributor.author | Streinu-cercel, Adrian | |
| dc.date.accessioned | 2021-03-03T15:32:05Z | |
| dc.date.available | 2021-03-03T15:32:05Z | |
| dc.identifier.citation | Sonneveld M. J. , Xie Q., Zhang N., Zhang Q., Tabak F., Streinu-cercel A., Wang J., İDİLMAN R., de Niet A., Diculescu M., et al., "Adding peginterferon alfa-2a to entecavir increases HBsAg decline and HBeAg clearance - first results from a global randomized trial (ARES study)", 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 9 - 13 Kasım 2012, cilt.56 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_3f6f78f5-56e1-4238-8d3e-951d2beb97b3 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/46452 | |
| dc.language.iso | eng | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Gastroenteroloji-(Hepatoloji) | |
| dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Tıp | |
| dc.title | Adding peginterferon alfa-2a to entecavir increases HBsAg decline and HBeAg clearance - first results from a global randomized trial (ARES study) | |
| dc.type | Bildiri | |
| dc.contributor.department | Erasmus University Rotterdam , , | |
| dc.identifier.volume | 56 | |
| dc.contributor.firstauthorID | 140564 | |
